111, Inc.

YISEC EDGAR

Retail-Drug Stores and Proprietary Stores(E9)CIK: 1738906

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	$13.5B	$12.4B	$8.2B	$4.0B	$1.8B
Cost of Goods and Services Sold	$12.7B	$11.8B	$7.8B	$3.8B	$73.9M
Gross Profit	$840.0M	$621.1M	$365.8M	$165.2M	$104.3M
Operating Income (Loss)	-$371.0M	-$642.1M	-$473.3M	-$493.5M	-$400.4M
Interest Expense	—	$5.5M	$8.8M	$3.6M	$3.6M
Other Nonoperating Income (Expense)	$8.1M	$14.9M	$3.2M	$834.0K	$11.5M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$376.1M	-$621.0M	-$467.1M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$3.1B	$3.5B	$3.1B	$3.0B	$1.6B
Assets, Current	$2.9B	$3.2B	$2.8B	$2.9B	$1.5B
Cash and Cash Equivalents, at Carrying Value	$673.7M	$661.4M	$1.2B	$581.3M	$853.7M
Accounts Receivable, after Allowance for Credit Loss, Current	$488.9M	$404.5M	$163.1M	$65.2M	$28.6M
Inventory, Net	$1.4B	$1.5B	$1.1B	$766.5M	$486.3M
Liabilities	$2.8B	$2.8B	$2.3B	$1.7B	$836.4M
Liabilities, Current	$2.7B	$2.7B	$2.1B	$1.6B

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$23.2M	-$688.8M	-$116.8M	-$512.4M	-$343.0M
Net Cash Provided by (Used in) Investing Activities	-$47.2M	$60.1M	-$324.7M	$237.7M	$44.5M
Net Cash Provided by (Used in) Financing Activities	$22.7M	$74.3M	$1.1B	$109.0M	$972.7M
Payments to Acquire Property, Plant, and Equipment	$31.6M	$62.6M	$25.5M	$20.0M	$14.4M
Payments for Repurchase of Common Stock	—	$5.9M	$12.0M	$23.0M	$23.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)